vTv Therapeutics Inc.VTVTNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | -100.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | -100.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +167.85% | +176.79% | +58.95% | +2.87% | +47.64% |
| Weighted Average Shares Diluted Growth | +167.85% | +176.79% | +58.95% | +2.87% | +47.64% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -39.22% | -100.00% | -100.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +189.23% | +247.30% | -40.89% | -43.07% | +130.50% |
| Book Value per Share Growth | +0.00% | +0.00% | -76.04% | -83.70% | +218.36% |
| Debt Growth | -74.97% | -68.05% | -58.05% | -69.14% | +69.01% |
| R&D Expense Growth | +14.16% | +4.49% | +6.83% | +19.31% | +117.74% |
| SG&A Expenses Growth | +29.01% | +4.13% | -7.67% | -2.64% | +12.10% |